$BSX
AI 分析生成于 May 11, 2026
AI Score
Buy$BSX
Boston Scientific Corporation
$BSXNYSEHealthcareLarge-Cap
Boston Scientific develops medical devices for interventional cardiology, cardiac rhythm management, neuromodulation, and endoscopy.
Market Cap
$120.0B
Revenue (TTM)
$16.5B
+18.0%
Net Income (TTM)
$2.2B
+25.0%
EPS (TTM)
$1.50
P/E Ratio
55.0
Dividend Yield
0.0%
52-Week Range
$55-$95
Beta
0.82
Dimension Scores
Fundamental
72Technical
72Sentiment
78Risk / Reward
72Momentum
78Financial Health
Profitability
77strong
Growth
81strong
Liquidity
80strong
Solvency
74strong
Efficiency
70strong
Valuation, technical analysis, investment thesis, risk assessment and more for $BSX
Free · No credit card required
免责声明: AI 生成的分析仅供教育参考,不构成投资建议。请始终咨询合格的理财顾问。